Clinical Trials on Non-Small Cell Lung Cancer in Austria
Total 1232 results
-
AmgenTerminatedNSCLC | Non-small Cell Lung CancerUnited States, Austria, Australia
-
Medical University InnsbruckMerck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerAustria
-
Uptake Medical Technology, Inc.Not yet recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung CancerAustria, Italy
-
Central European Cooperative Oncology GroupTerminatedNon Small Cell Lung CancerAustria
-
Medical University of ViennaUnknownAdvanced Non-small-cell Lung CancerAustria
-
Uptake Medical Technology, Inc.CompletedLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung CancerAustralia
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Austria, Spain
-
Medical University of ViennaUnknownNon Small Cell Lung CancerAustria
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustria
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
AmgenActavis Inc.CompletedNon-small Cell Lung Cancer MetastaticUnited States, Bulgaria, Australia
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon Small Cell Lung Cancer Stage IIIAustralia
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Trans Tasman Radiation Oncology GroupUnknownNon Small Cell Lung CancerAustralia, New Zealand
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, United Kingdom, Spain
-
Radiopharm Theranostics, LtdRecruitingNon Small Cell Lung Cancer | PDL1 Gene MutationAustralia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
University of Texas Southwestern Medical CenterCompletedNon-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
Western Sydney Local Health DistrictUniversity of Western SydneyRecruitingHepatitis | Lung Cancer, Non-small Cell | Lung Cancer Stage IVAustralia
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Central European Cooperative Oncology GroupTerminatedNon-Small Cell Lung CancerAustria, Hungary, Poland
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerAustralia
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
NeoTX Therapeutics Ltd.Translational Drug DevelopmentCompleted
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore